Lichenstein, Sarah D.
Scheinost, Dustin
Potenza, Marc N.
Carroll, Kathleen M.
Yip, Sarah W.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (T32DA022975, R01DA035058, K01DA039299, R21DA045969)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 9 April 2019
Revised: 14 October 2019
Accepted: 28 October 2019
First Online: 12 November 2019
Compliance with ethical standards
:
: SDL, DS, and SWY report no financial relationships with commercial interest. KMC has received multiple grants from NIDA and NIAAA. She is a member of CBT4CBT LLC; this is managed through University. MNP has received financial support or compensation for the following: MNP has consulted for and advised RiverMend Health and Opiant/Lakelight Therapeutics; has received unrestricted research support from Mohegan Sun Casino and grant support from the National Center for Responsible Gaming; and has consulted for legal and gambling entities on issues related to addictive disorders.